Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2022-02-14 11:52 am Purchase |
2021-12-31 | 13G | Lionheart Acquisition Corporation II LCAP |
MARSHALL WACE LLP | 1,197,522 5.060% |
1,197,522 (New Position) |
Filing History |
| 2022-02-14 11:49 am Purchase |
2021-12-31 | 13G | HumanCo Acquisition Corp. HMCO |
MARSHALL WACE LLP | 1,806,980 5.780% |
1,806,980 (New Position) |
Filing History |
| 2022-02-14 11:47 am Purchase |
2021-12-31 | 13G | Fortress Value Acquisition Corp. IV FVIV |
MARSHALL WACE LLP | 3,266,946 5.030% |
3,266,946 (New Position) |
Filing History |
| 2022-02-14 11:44 am Purchase |
2021-12-31 | 13G | HH&L Acquisition Co. HHLA |
MARSHALL WACE LLP | 2,311,227 5.580% |
2,311,227 (New Position) |
Filing History |
| 2022-02-14 11:40 am Unchanged |
2021-12-31 | 13G | Gelesis Holdings, Inc. GLSHQ |
MARSHALL WACE LLP | 0 0.000% |
0 (Unchanged) |
Filing History |
| 2022-02-14 11:37 am Unchanged |
2021-12-31 | 13G | Decarbonization Plus Acquisition Corporation II DCRN |
MARSHALL WACE LLP | 0 0.000% |
0 (Unchanged) |
Filing History |
| 2022-02-14 11:17 am Purchase |
2021-12-31 | 13G | FAST Acquisition Corp. FST |
MARSHALL WACE LLP | 1,500,000 7.500% |
1,500,000 (New Position) |
Filing History |
| 2022-02-14 11:13 am Unchanged |
2021-12-31 | 13G | Dave Inc. DAVE |
MARSHALL WACE LLP | 0 0.000% |
0 (Unchanged) |
Filing History |
| 2022-02-14 11:10 am Purchase |
2021-12-31 | 13G | Quanergy Systems, Inc. QNGY |
MARSHALL WACE LLP | 30,390 0.730% |
30,390 (New Position) |
Filing History |
| 2022-02-14 11:03 am Purchase |
2021-12-31 | 13G | Apollo Strategic Growth Capital APSG |
MARSHALL WACE LLP | 6,109,059 7.480% |
6,109,059 (New Position) |
Filing History |
| 2022-02-14 11:01 am Purchase |
2021-12-31 | 13G | AEA-Bridges Impact Corp. IMPX |
MARSHALL WACE LLP | 2,012,116 5.030% |
2,012,116 (New Position) |
Filing History |
| 2021-02-16 09:56 am Sale |
2020-12-31 | 13G | Esperion Therapeutics, Inc. ESPR |
MARSHALL WACE LLP | 1,370,352 4.900% |
-157,749 (-10.32%) |
Filing History |
| 2021-02-04 4:05 pm Purchase |
2021-01-25 | 13G | VG Acquisition Corp. VGAC |
MARSHALL WACE LLP | 2,626,787 5.200% |
2,626,787 (New Position) |
Filing History |
| 2020-06-15 4:44 pm Purchase |
2020-06-03 | 13G | Esperion Therapeutics, Inc. ESPR |
MARSHALL WACE LLP | 1,528,101 5.500% |
1,528,101 (New Position) |
Filing History |